Clinical Trials · NCT06287307
Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Zuyderland Medisch Centrum
- Enrollment
- 152
- Start date
- May 2024
- Locations
- See registry
- Primary endpoint
- Weight change from start study at 3 months post operative until 15 months later